Drug intelligence / Profile preview

vaporized cannabis

Development stage
Unknown
Lead developer
University of California, San Diego
Modality
Small Molecules
Administration
Inhalation
01

Overview

A clinical research program led by the University of California, San Diego (UCSD) investigating the use of vaporized cannabis flower for the acute treatment of migraine. The research evaluates different potencies and ratios of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), including THC-dominant (up to 10% THC), CBD-dominant, and combination formulations. The mechanism of action is believed to involve the activation of cannabinoid receptors (CB1 and CB2), which in turn inhibits the release of calcitonin gene-related peptide (CGRP), reduces CGRP-induced nitric oxide release, and suppresses trigeminovascular neurons and cortical spreading depression. The study was conducted as a randomized, double-blind, placebo-controlled crossover trial, with the combination formulation showing superior efficacy compared to placebo.

Other names
inhaled cannabisvaporized cannabis flowerTHCCBDTHC/CBD combination
02

Targets

CB2 (Cannabinoid receptor 2)

Beyond the preview

Go deeper on vaporized cannabis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on vaporized cannabis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call